Share your thoughts, experiences and ideas which could help others.
Please, no commercial content and no spam.
Make sure you enter your email address correctly so we can let you know when it goes live after a short moderation process.
Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer...
Read more on Wikipedia
Positive Experiences with Pulmonary Hypertension
Based on 438 patient discussions on healthcare websites and blogs.
...pulmonary hypertension and see if you should begin treatment immediately. That's what I would do, and I would do it this week. Just like heart failure, PH requires immediate treatment - bosentan ha...